Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Minority-Interest-Expense" stands at 10.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2023.
Merck & Company Inc's third quarter result of 2.00 Million USD for the item "Minority Interest Expense" represents an increase of 100.00 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of 2.00 Million USD for the item "Minority Interest Expense" represents a decrease of -50.00 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 10.00 Million USD for the item "Minority Interest Expense" represents a decrease of -16.67 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -5.00 Million United States Dollars compared to the value the year prior.
The 1 year change is -5.00 Million United States Dollars.
The 3 year change is -59.00 Million United States Dollars.
The 5 year change is 124.00 Million United States Dollars.
The 10 year change is 33.00 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Minority Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Minority Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Minority Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Minority Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Minority Interest Expense | 280,205,508,085.11 |